MAPK/ERK


The mitogen-activated protein kinase (MAPK) is a highly conserved family of serine/threonine kinases that mediate a board range of cellular processes, including proliferation, differentiation, motility, migration, stress response, apoptosis and survival. The activation of MAPK involves signaling pathways consisting of MAPK kinase (i.e. MAPKKK or MEKK) that activates MAPK/ERK (i.e. MAPKK or MEK). A variety of extracellular signals such as mitogens, cytokines, growth factors, and environmental stressors stimulate a phosphorylation-dependent increase in the activity of MAPK.
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B1405 GW50742 CitationSummary: C-Raf inhibitor,potent and selective -
B1406 SB5908851 CitationSummary: Potent B-Raf inhibitor -
B1260 CC-401Summary: JNK inhibitor,ATP-competitive -
B1621 TAK-733Target: MEKSummary: MEK allosteric site inhibitor -
B9000 8-Bromo-cAMP, sodium saltTarget: PKASummary: Cell-permeable cAMP analog that activates PKA -
B9002 KT 5720Summary: protein kinase A inhibitor, potent and selective -
B9003 cAMPS-Sp, triethylammonium saltSummary: Cell-permeable cAMP analog that activates cAMP receptor protein PKA -
B9004 cAMPS-Rp, triethylammonium saltSummary: Cell-permeable cAMP analog, competitive antagonist of cAMP-induced activation of PKA -
B9006 cGMP Dependent Kinase Inhibitor PeptideSummary: cGMP-dependent protein kinase (PKG) inhibitor -
B9008 SL 0101-1Summary: ribosomal S6 kinase inhibitor

